$3.48
al cierre: Nov 12, 5:03 PM EDT
$3.40
-0.08-2.30%
After hour: 5:03 PM EDT
BioLine Rx informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de BioLine Rx utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
BLRX | BioLine Rx | -$0.07 | -$0.49 | — | — | $4.94M | $606.00K | — | — | 11/24/2025 | |
BLRX | BioLine Rx | $0.00 | -$0.46 | -$1.00 | -117.39% | $5.39M | $608.80K | $304.00K | -50.07% | 08/14/2025 | |
BLRX | BioLine Rx | -$0.01 | -$1.06 | $0.00 | 100.09% | $6.86M | $1.48M | $255.00K | -82.77% | 05/27/2025 | |
BLRX | BioLine Rx | -$0.15 | $0.00 | $0.00 | — | $4.80M | $7.72M | $11.75M | 52.19% | 03/31/2025 | |
BLRX | BioLine Rx | -$0.26 | -$0.10 | -$0.07 | 30.00% | $0.00 | $4.12M | $4.94M | 19.98% | 11/25/2024 | |
BLRX | BioLine Rx | -$0.30 | -$0.14 | $0.00 | 100.00% | $0.00 | $3.93M | $5.39M | 37.23% | 08/15/2024 | |
BLRX | BioLine Rx | -$0.10 | -$0.29 | -$0.01 | 96.55% | $0.00 | — | $6.86M | — | 05/28/2024 | |
BLRX | BioLine Rx | -$0.08 | -$0.22 | -$0.15 | 31.82% | $0.00 | — | $4.80M | — | 03/26/2024 | |
BLRX | BioLine Rx | -$0.02 | -$0.21 | -$0.26 | -23.81% | $0.00 | — | $0.00 | — | 11/20/2023 | |
BLRX | BioLine Rx | -$0.02 | — | -$0.30 | — | $0.00 | — | $0.00 | — | 08/30/2023 | |
BLRX | BioLine Rx | -$0.10 | — | -$0.10 | — | $0.00 | — | $0.00 | — | 05/24/2023 | |
BLRX | BioLine Rx | -$0.18 | -$0.14 | -$0.08 | 42.86% | $0.00 | — | $0.00 | — | 03/22/2023 | |
BLRX | BioLine Rx | -$0.01 | -$0.11 | -$0.15 | -36.36% | $0.00 | — | $0.00 | — | 11/15/2022 | |
BLRX | BioLine Rx | -$0.15 | -$0.07 | -$0.15 | -114.29% | $0.00 | — | $0.00 | — | 08/16/2022 | |
BLRX | BioLine Rx | -$0.02 | -$0.15 | -$0.10 | 33.33% | $0.00 | — | $0.00 | — | 05/11/2022 | |
BLRX | BioLine Rx | -$0.60 | -$0.14 | -$0.18 | -28.57% | $0.00 | — | $0.00 | — | 03/16/2022 | |
BLRX | BioLine Rx | -$0.30 | -$0.16 | -$0.15 | 6.25% | $0.00 | — | $0.00 | — | 11/18/2021 | |
BLRX | BioLine Rx | -$0.45 | -$0.15 | -$0.15 | 0.00% | $0.00 | — | $0.00 | — | 08/18/2021 | |
BLRX | BioLine Rx | -$0.60 | -$0.15 | -$0.30 | -100.00% | $0.00 | — | $0.00 | — | 05/26/2021 | |
BLRX | BioLine Rx | -$0.90 | -$0.27 | -$0.60 | -122.22% | $0.00 | — | $0.00 | — | 02/23/2021 | |
BLRX | BioLine Rx | -$0.45 | -$0.35 | -$0.30 | 14.29% | $0.00 | — | $0.00 | — | 11/23/2020 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-1.00 | $-0.46 | -117.4 % |
| Q1 | 2025-05-27 | $0 | $-1.06 | 100.1 % |
| Q3 | 2024-11-25 | $-0.07 | $-0.10 | 30.0 % |
| Q2 | 2024-08-15 | $0 | $-0.14 | 100.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $304.00K | $608.80K | -50.1 % |
| Q1 | 2025-05-27 | $255.00K | $1.48M | -82.8 % |
| Q4 | 2025-03-31 | $11.75M | $7.72M | 52.2 % |
| Q3 | 2024-11-25 | $4.94M | $4.12M | 20.0 % |
Está previsto que BioLine Rx (BLRX) presente resultados el noviembre 24, 2025. Los últimos resultados se publicaron el agosto 14, 2025 para el Q2.
El BPA real fue de $-1.00, que no alcanzó la estimación de $-0.46.
Los ingresos reales fueron $304K, que no alcanzó la estimación de $608.8K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.